Confluence Wealth Services, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1910411 MCMURRAY, PA

Position in VRTX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$815,630

+$571,373 QoQ

Shares Held

1,642

+200.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#278

of 646 holders

Holding Since

Dec 2021

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Confluence Wealth Services, Inc. holds $2,485,829 across 5 Biotechnology names. VRTX ranks #2 (32.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	3,792	$1,409,372
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,642	$815,630
3	DFTX	Definium Therapeutics, Inc.	4,796	$225,603
4	CHRS	Coherus Oncology, Inc.	19,803	$27,724
5	VTGN	Vistagen Therapeutics, Inc.	32,610	$7,500

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$815,630	1,642	+200.2%	Shares	Sole	2026-07-22
2026-03-31	$244,257	547	+0.4%	Shares	Sole	2026-05-07
2025-12-31	$247,081	545	+4.0%	Shares	Sole	2026-01-28
2025-09-30	$205,219	524	-31.2%	Shares	Sole	2025-10-28
2024-06-30	$357,164	762	+109.9%	Shares	Sole	2024-07-31
2021-12-31	$79,714	363	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.